{
  "DOI": "10.1186/s40246-022-00414-y",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-022-00414-y",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\u003cjats:title\u003eBackground\u003c/jats:title\u003e\u003cjats:p\u003eCBL syndrome is a RASopathy caused by heterozygous germline mutations of the Casitas B-lineage lymphoma (CBL) gene. It is characterized by heterogeneous clinical phenotype, including developmental delay, facial dysmorphisms, cardiovascular malformations and an increased risk of cancer development, particularly juvenile myelomonocytic leukemia (JMML). Although the clinical phenotype has been progressively defined in recent years, immunological manifestations have not been well elucidated to date.\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eMethods\u003c/jats:title\u003e\u003cjats:p\u003eWe studied the genetic, immunological, coagulative, and clinical profile of a family with CBL syndrome that came to our observation after the diagnosis of JMML, with homozygous CBL mutation, in one of the members.\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eResults\u003c/jats:title\u003e\u003cjats:p\u003eVariant analysis revealed the co-occurrence of CBL heterozygous mutation (c.1141 T \u0026gt; \u003cjats:italic\u003eC\u003c/jats:italic\u003e) and\u003cjats:italic\u003eSH2B3\u003c/jats:italic\u003emutation (c.1697G \u0026gt; \u003cjats:italic\u003eA\u003c/jats:italic\u003e) in two other members. Patients carrying both mutations showed an ALPS-like phenotype characterized by lymphoproliferation, cytopenia, increased double-negative T-cells, impaired Fas-mediated lymphocyte apoptosis, altered cell death in PBMC and low TRECs expression. A coagulative work-up was also performed and showed the presence of subclinical coagulative alterations in patients carrying both mutations.\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eConclusion\u003c/jats:title\u003e\u003cjats:p\u003eIn the reported family, we described immune dysregulation, as part of the clinical spectrum of CBL mutation with the co-occurrence of SH2B3.\u003c/jats:p\u003e\u003c/jats:sec\u003e",
  "alternative-id": [
    "414"
  ],
  "article-number": "40",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "9 July 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "11 September 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "19 September 2022"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Baccelli",
      "given": "Francesco",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Leardini",
      "given": "Davide",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Muratore",
      "given": "Edoardo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Messelodi",
      "given": "Daria",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bertuccio",
      "given": "Salvatore Nicola",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chiriaco",
      "given": "Maria",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cancrini",
      "given": "Caterina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Conti",
      "given": "Francesca",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Castagnetti",
      "given": "Fausto",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pedace",
      "given": "Lucia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pession",
      "given": "Andrea",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yoshimi",
      "given": "Ayami",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Niemeyer",
      "given": "Charlotte",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tartaglia",
      "given": "Marco",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Locatelli",
      "given": "Franco",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Masetti",
      "given": "Riccardo",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        9,
        19
      ]
    ],
    "date-time": "2022-09-19T11:03:12Z",
    "timestamp": 1663585392000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        2,
        19
      ]
    ],
    "date-time": "2023-02-19T15:03:12Z",
    "timestamp": 1676818992000
  },
  "funder": [
    {
      "DOI": "10.13039/501100005010",
      "award": [
        "IG-21614",
        "IG-21724",
        "IG-26039"
      ],
      "doi-asserted-by": "crossref",
      "name": "Associazione Italiana per la Ricerca sul Cancro"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        16
      ]
    ],
    "date-time": "2024-04-16T15:13:20Z",
    "timestamp": 1713280400312
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2022,
        9,
        19
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2022,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            9,
            19
          ]
        ],
        "date-time": "2022-09-19T00:00:00Z",
        "timestamp": 1663545600000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            9,
            19
          ]
        ],
        "date-time": "2022-09-19T00:00:00Z",
        "timestamp": 1663545600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00414-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-022-00414-y/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00414-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2022,
        9,
        19
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        9,
        19
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/j.ajhg.2010.06.015",
      "author": "S Martinelli",
      "doi-asserted-by": "publisher",
      "first-page": "250",
      "journal-title": "Am J Hum Genet",
      "key": "414_CR1",
      "unstructured": "Martinelli S, De Luca A, Stellacci E, Rossi C, Checquolo S, Lepri F, et al. Heterozygous germline mutations in the CBL tumor-suppressor gene cause a noonan syndrome-like phenotype. Am J Hum Genet. 2010;87:250–7. https://doi.org/10.1016/j.ajhg.2010.06.015.",
      "volume": "87",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nrm1762",
      "author": "MHH Schmidt",
      "doi-asserted-by": "publisher",
      "first-page": "907",
      "journal-title": "Nat Rev Mol Cell Biol",
      "key": "414_CR2",
      "unstructured": "Schmidt MHH, Dikic I. The Cbl interactome and its functions. Nat Rev Mol Cell Biol. 2005;6:907–18.",
      "volume": "6",
      "year": "2005"
    },
    {
      "DOI": "10.1002/humu.22809",
      "author": "S Martinelli",
      "doi-asserted-by": "publisher",
      "first-page": "787",
      "journal-title": "Hum Mutat",
      "key": "414_CR3",
      "unstructured": "Martinelli S, Stellacci E, Pannone L, D’Agostino D, Consoli F, Lissewski C, et al. Molecular diversity and associated phenotypic spectrum of germline CBL mutations. Hum Mutat. 2015;36:787–96.",
      "volume": "36",
      "year": "2015"
    },
    {
      "DOI": "10.1136/jmg.2010.076836",
      "author": "B Pérez",
      "doi-asserted-by": "publisher",
      "first-page": "686",
      "journal-title": "J Med Genet",
      "key": "414_CR4",
      "unstructured": "Pérez B, Mechinaud F, Galambrun C, Ben Romdhane N, Isidor B, Philip N, et al. Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia. J Med Genet. 2010;47:686–91.",
      "volume": "47",
      "year": "2010"
    },
    {
      "DOI": "10.1111/j.1749-6632.2010.05790.x",
      "author": "M Tartaglia",
      "doi-asserted-by": "publisher",
      "first-page": "99",
      "journal-title": "Ann NY Acad Sci",
      "key": "414_CR5",
      "unstructured": "Tartaglia M, Gelb BD. Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms. Ann NY Acad Sci. 2010;1214:99–121.",
      "volume": "1214",
      "year": "2010"
    },
    {
      "DOI": "10.1038/ng.641",
      "author": "CM Niemeyer",
      "doi-asserted-by": "publisher",
      "first-page": "794",
      "issue": "9",
      "journal-title": "Nat Genet",
      "key": "414_CR6",
      "unstructured": "Niemeyer CM, Kang MW, Shin DH, Furlan I, Erlacher M, Bunin NJ, Bunda S, Finklestein JZ, Sakamoto KM, Gorr TA, Mehta P. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic Leukemia. Nat Genet. 2010;42(9):794–800.",
      "volume": "42",
      "year": "2010"
    },
    {
      "DOI": "10.1182/blood-2009-01-198416",
      "author": "ML Loh",
      "doi-asserted-by": "publisher",
      "first-page": "1859",
      "journal-title": "Blood",
      "key": "414_CR7",
      "unstructured": "Loh ML, Sakai DS, Flotho C, Kang M, Fliegauf M, Archambeault S, et al. Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood. 2009;114:1859–63.",
      "volume": "114",
      "year": "2009"
    },
    {
      "DOI": "10.3389/fped.2015.00037",
      "author": "R Masetti",
      "doi-asserted-by": "publisher",
      "journal-title": "Front Pediatr",
      "key": "414_CR8",
      "unstructured": "Masetti R, Vendemini F, Zama D, Biagi C, Pession A, Locatelli F. Acute myeloid leukemia in infants: biology and treatment. Front Pediatr. https://doi.org/10.3389/fped.2015.00037",
      "year": "2015"
    },
    {
      "DOI": "10.1038/leu.2013.203",
      "author": "M Strullu",
      "doi-asserted-by": "publisher",
      "first-page": "2404",
      "issue": "12",
      "journal-title": "Leukemia",
      "key": "414_CR9",
      "unstructured": "Strullu M, Caye A, Cassinat B, Fenneteau O, Touzot F, Blauwblomme T, et al. In hematopoietic cells with a germline mutation of CBL, loss of heterozygosity is not a signature of juvenile myelo-monocytic leukemia. Leukemia. 2013;27(12):2404–7. https://doi.org/10.1038/leu.2013.203.",
      "volume": "27",
      "year": "2013"
    },
    {
      "DOI": "10.1136/jmedgenet-2016-104432",
      "author": "S Guey",
      "doi-asserted-by": "publisher",
      "first-page": "550",
      "journal-title": "J Med Genet",
      "key": "414_CR10",
      "unstructured": "Guey S, Grangeon L, Brunelle F, Bergametti F, Amiel J, Lyonnet S, et al. De novo mutations in CBL causing early-onset paediatric moyamoya angiopathy. J Med Genet. 2017;54:550–7.",
      "volume": "54",
      "year": "2017"
    },
    {
      "DOI": "10.1097/MPH.0000000000001448",
      "author": "L Cortellazzo Wiel",
      "doi-asserted-by": "publisher",
      "first-page": "e373",
      "journal-title": "J Pediatr Hematol Oncol",
      "key": "414_CR11",
      "unstructured": "Cortellazzo Wiel L, Pastore S, Taddio A, Tommasini A. A case of uveitis in a patient with juvenile myelomonocytic leukemia successfully treated with adalimumab. J Pediatr Hematol Oncol. 2020;42:e373–6.",
      "volume": "42",
      "year": "2020"
    },
    {
      "DOI": "10.1111/bjh.17234",
      "author": "AM Ali",
      "doi-asserted-by": "publisher",
      "first-page": "665",
      "issue": "3",
      "journal-title": "Br J Haematol",
      "key": "414_CR12",
      "unstructured": "Ali AM, Cooper J, Walker A, Jones D, Saad A. Adult‐onset acute myeloid leukaemia in a patient with germline mutation of CBL. Br J Haematol. 2021;192(3):665–7. https://doi.org/10.1111/bjh.17234.",
      "volume": "192",
      "year": "2021"
    },
    {
      "DOI": "10.1074/jbc.M109.094920",
      "author": "CBF Thien",
      "doi-asserted-by": "publisher",
      "first-page": "10969",
      "issue": "14",
      "journal-title": "J Biol Chem",
      "key": "414_CR13",
      "unstructured": "Thien CBF, Dagger SA, Steer JH, Koentgen F, Jansen ES, Scott CL, et al. c-Cbl promotes T cell receptor-induced thymocyte apoptosis by activating the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem. 2010;285(14):10969–81. https://doi.org/10.1074/jbc.M109.094920.",
      "volume": "285",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.immuni.2007.03.015",
      "author": "Y Kitaura",
      "doi-asserted-by": "publisher",
      "first-page": "567",
      "journal-title": "Immunity",
      "key": "414_CR14",
      "unstructured": "Kitaura Y, Jang IK, Wang Y, Han YC, Inazu T, Cadera EJ, et al. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b. Immunity. 2007;26:567–78.",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1038/ni855",
      "author": "M Naramura",
      "doi-asserted-by": "publisher",
      "first-page": "1192",
      "journal-title": "Nat Immunol",
      "key": "414_CR15",
      "unstructured": "Naramura M, Jang I-K, Kole H, Huang F, Haines D, Gu H. c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. Nat Immunol. 2002;3:1192–9.",
      "volume": "3",
      "year": "2002"
    },
    {
      "DOI": "10.3390/cells8050498",
      "author": "CL Lyle",
      "doi-asserted-by": "publisher",
      "first-page": "498",
      "journal-title": "Cells",
      "key": "414_CR16",
      "unstructured": "Lyle CL, Belghasem M, Chitalia VC. c-Cbl: an important regulator and a target in angiogenesis and tumorigenesis. Cells. 2019;8:498.",
      "volume": "8",
      "year": "2019"
    },
    {
      "DOI": "10.3390/ph15010024",
      "author": "R Morris",
      "doi-asserted-by": "publisher",
      "first-page": "24",
      "issue": "1",
      "journal-title": "Pharmaceuticals (Basel)",
      "key": "414_CR17",
      "unstructured": "Morris R, Butler L, Perkins A, Kershaw NJ, Babon JJ. The role of LNK (SH2B3) in the regulation of JAK-STAT signalling in haematopoiesis. Pharmaceuticals (Basel). 2021;15(1):24.",
      "volume": "15",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.bcp.2011.06.023",
      "author": "J Devallire",
      "doi-asserted-by": "publisher",
      "first-page": "1391",
      "journal-title": "Biochem Pharmacol",
      "key": "414_CR18",
      "unstructured": "Devallire J, Charreau B. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling. Biochem Pharmacol. 2011;82:1391–402.",
      "volume": "82",
      "year": "2011"
    },
    {
      "author": "N Maslah",
      "first-page": "1661",
      "journal-title": "Leukemia Nat Publish Group",
      "key": "414_CR19",
      "unstructured": "Maslah N, Cassinat B, Verger E, Kiladjian JJ, Velazquez L. The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders. Leukemia Nat Publish Group. 2017;31:1661–70.",
      "volume": "31",
      "year": "2017"
    },
    {
      "DOI": "10.1002/ajh.25552",
      "author": "G Coltro",
      "doi-asserted-by": "publisher",
      "first-page": "E231",
      "journal-title": "Am J Hematol",
      "key": "414_CR20",
      "unstructured": "Coltro G, Lasho TL, Finke CM, Gangat N, Pardanani A, Tefferi A, et al. Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis. Am J Hematol. 2019;94:E231–4.",
      "volume": "94",
      "year": "2019"
    },
    {
      "DOI": "10.1182/blood-2013-05-500850",
      "author": "A Perez-Garcia",
      "doi-asserted-by": "publisher",
      "first-page": "2425",
      "journal-title": "Blood",
      "key": "414_CR21",
      "unstructured": "Perez-Garcia A, Ambesi-Impiombato A, Hadler M, Rigo I, LeDuc CA, Kelly K, et al. Genetic loss of SH2B3 in acute lymphoblastic leukemia. Blood. 2013;122:2425–32.",
      "volume": "122",
      "year": "2013"
    },
    {
      "DOI": "10.1111/j.1399-5448.2010.00656.x",
      "author": "EY Lavrikova",
      "doi-asserted-by": "publisher",
      "first-page": "127",
      "journal-title": "Pediatr Diabetes",
      "key": "414_CR22",
      "unstructured": "Lavrikova EY, Nikitin AG, Kuraeva TL, Peterkova VA, Tsitlidze NM, Chistiakov DA, et al. The carriage of the type 1 diabetes-associated R262W variant of human LNK correlates with increased proliferation of peripheral blood monocytes in diabetic patients. Pediatr Diabetes. 2011;12:127–32.",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.3390/cancers14030839",
      "author": "D Leardini",
      "doi-asserted-by": "publisher",
      "first-page": "839",
      "issue": "3",
      "journal-title": "Cancers",
      "key": "414_CR23",
      "unstructured": "Leardini D, Messelodi D, Muratore E, Baccelli F, Bertuccio SN, Anselmi L, et al. Role of CBL mutations in cancer and non-malignant phenotype. Cancers. 2022;14(3):839. https://doi.org/10.3390/cancers14030839.",
      "volume": "14",
      "year": "2022"
    },
    {
      "author": "CM Niemeyer",
      "first-page": "3534",
      "journal-title": "Blood",
      "key": "414_CR24",
      "unstructured": "Niemeyer CM, Aricó M, Basso G, Biondi A, Cantú Rajnoldi A, Creutzig U, et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. Blood. 1997;89:3534–43.",
      "volume": "89",
      "year": "1997"
    },
    {
      "DOI": "10.1182/blood-2010-04-280347",
      "author": "JB Oliveira",
      "doi-asserted-by": "publisher",
      "first-page": "35",
      "journal-title": "Blood",
      "key": "414_CR25",
      "unstructured": "Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116:35–40.",
      "volume": "116",
      "year": "2010"
    },
    {
      "DOI": "10.1097/BOR.0000000000000778",
      "author": "H Li",
      "doi-asserted-by": "publisher",
      "first-page": "163",
      "journal-title": "Curr Opin Rheumatol",
      "key": "414_CR26",
      "unstructured": "Li H, Tsokos GC. Double-negative T cells in autoimmune diseases. Curr Opin Rheumatol. 2021;33:163–72.",
      "volume": "33",
      "year": "2021"
    },
    {
      "DOI": "10.1182/blood-2010-09-306910",
      "author": "TB Russell",
      "doi-asserted-by": "publisher",
      "first-page": "5072",
      "journal-title": "Blood",
      "key": "414_CR27",
      "unstructured": "Russell TB, Kurre P. Double-negative T cells are non-ALPS-specific markers of immune dysregulation found in patients with aplastic anemia. Blood. 2010;116:5072–3.",
      "volume": "116",
      "year": "2010"
    },
    {
      "DOI": "10.1371/journal.pone.0170270",
      "author": "JV Steenholt",
      "doi-asserted-by": "publisher",
      "first-page": "e0170270",
      "journal-title": "PLoS One.",
      "key": "414_CR28",
      "unstructured": "Steenholt JV, Nielsen C, Baudewijn L, Staal A, Rasmussen KS, Sabir HJ, et al. The composition of T cell subtypes in duodenal biopsies are altered in coeliac disease patients. PLoS One. 2017;12:e0170270.",
      "volume": "12",
      "year": "2017"
    },
    {
      "DOI": "10.1073/pnas.0702975104",
      "author": "JB Oliveira",
      "doi-asserted-by": "publisher",
      "first-page": "8953",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "414_CR29",
      "unstructured": "Oliveira JB, Bidère N, Niemela JE, Zheng L, Sakai K, Nix CP, et al. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci USA. 2007;104:8953–8.",
      "volume": "104",
      "year": "2007"
    },
    {
      "DOI": "10.1182/blood-2010-08-301515",
      "author": "MM Takagi",
      "doi-asserted-by": "publisher",
      "first-page": "2887",
      "journal-title": "Blood Am Soc Hematol",
      "key": "414_CR30",
      "unstructured": "Takagi MM, Shinoda K, Piao J, Mitsuiki N, Takagi MM, Matsuda K, et al. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation. Blood Am Soc Hematol. 2011;117:2887–90. https://doi.org/10.1182/blood-2010-08-301515.",
      "volume": "117",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.cell.2017.06.009",
      "author": "DK Simanshu",
      "doi-asserted-by": "crossref",
      "first-page": "17",
      "journal-title": "Cell Elsevier",
      "key": "414_CR31",
      "unstructured": "Simanshu DK, Nissley DV, McCormick F. RAS proteins and their regulators in human disease. Cell Elsevier. 2017;170:17–33.",
      "volume": "170",
      "year": "2017"
    },
    {
      "DOI": "10.1182/blood-2014-11-567917",
      "author": "KR Calvo",
      "doi-asserted-by": "publisher",
      "first-page": "2753",
      "journal-title": "Blood",
      "key": "414_CR32",
      "unstructured": "Calvo KR, Price S, Braylan RC, Oliveira JB, Lenardo M, Fleisher TA, et al. JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities. Blood. 2015;125:2753–8.",
      "volume": "125",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10875-020-00883-7",
      "author": "Q Neven",
      "doi-asserted-by": "publisher",
      "first-page": "51",
      "issue": "1",
      "journal-title": "J Clin Immunol",
      "key": "414_CR33",
      "unstructured": "Neven Q, Boulanger C, Bruwier A, de Ville M, de Goyet I, Meyts LM, et al. Clinical spectrum of ras-associated autoimmune leukoproliferative disorder (RALD). J Clin Immunol. 2020;41(1):51–8. https://doi.org/10.1007/s10875-020-00883-7.",
      "volume": "41",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s12016-015-8466-y",
      "author": "P Li",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "journal-title": "Clin Rev Allergy Immunol",
      "key": "414_CR34",
      "unstructured": "Li P, Huang P, Yang Y, Hao M, Peng H, Li F. Updated understanding of autoimmune lymphoproliferative syndrome (ALPS). Clin Rev Allergy Immunol. 2016;50:55–63.",
      "volume": "50",
      "year": "2016"
    },
    {
      "DOI": "10.1111/bjh.12327",
      "author": "M Koren-Michowitz",
      "doi-asserted-by": "publisher",
      "first-page": "811",
      "journal-title": "Br J Haematol",
      "key": "414_CR35",
      "unstructured": "Koren-Michowitz M, Gery S, Tabayashi T, Lin D, Alvarez R, Nagler A, et al. SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F. Br J Haematol. 2013;161:811–20.",
      "volume": "161",
      "year": "2013"
    },
    {
      "DOI": "10.1182/bloodadvances.2020003754",
      "author": "CE Morales",
      "doi-asserted-by": "publisher",
      "first-page": "3587",
      "journal-title": "Blood Adv",
      "key": "414_CR36",
      "unstructured": "Morales CE, Stieglitz E, Kogan SC, Loh ML, Braun BS. Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia. Blood Adv. 2021;5:3587–91.",
      "volume": "5",
      "year": "2021"
    },
    {
      "DOI": "10.1038/ng2068",
      "author": "JA Todd",
      "doi-asserted-by": "publisher",
      "first-page": "857",
      "journal-title": "Nat Genet",
      "key": "414_CR37",
      "unstructured": "Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39:857–64.",
      "volume": "39",
      "year": "2007"
    },
    {
      "DOI": "10.1084/jem.20021498",
      "author": "CBF Thien",
      "doi-asserted-by": "publisher",
      "first-page": "503",
      "journal-title": "J Exp Med",
      "key": "414_CR38",
      "unstructured": "Thien CBF, Scaife RM, Papadimitriou JM, Murphy MA, Bowtell DDL, Langdon WY. A mouse with a loss-of-function mutation in the c-Cbl TKB domain shows perturbed thymocyte signaling without enhancing the activity of the ZAP-70 tyrosine kinase. J Exp Med. 2003;197:503–13.",
      "volume": "197",
      "year": "2003"
    },
    {
      "DOI": "10.4049/jimmunol.170.2.703",
      "author": "S Takaki",
      "doi-asserted-by": "publisher",
      "first-page": "703",
      "journal-title": "J Immunol.",
      "key": "414_CR39",
      "unstructured": "Takaki S, Tezuka Y, Sauer K, Kubo C, Kwon S-M, Armstead E, et al. Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing lnk adaptor protein. J Immunol. 2003;170:703–10.",
      "volume": "170",
      "year": "2003"
    },
    {
      "DOI": "10.1172/JCI81468",
      "author": "Y Cheng",
      "doi-asserted-by": "publisher",
      "first-page": "1267",
      "journal-title": "J Clin Invest",
      "key": "414_CR40",
      "unstructured": "Cheng Y, Chikwava K, Wu C, Zhang H, Bhagat A, Pei D, et al. LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors. J Clin Invest. 2016;126:1267–81.",
      "volume": "126",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.devcel.2005.03.019",
      "author": "H Ema",
      "doi-asserted-by": "publisher",
      "first-page": "907",
      "journal-title": "Dev Cell",
      "key": "414_CR41",
      "unstructured": "Ema H, Sudo K, Seita J, Matsubara A, Morita Y, Osawa M, et al. Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice. Dev Cell. 2005;8:907–14.",
      "volume": "8",
      "year": "2005"
    },
    {
      "DOI": "10.1084/jem.20011883",
      "author": "L Velazquez",
      "doi-asserted-by": "publisher",
      "first-page": "1599",
      "journal-title": "J Exp Med",
      "key": "414_CR42",
      "unstructured": "Velazquez L, Cheng AM, Fleming HE, Furlonger C, Vesely S, Bernstein A, et al. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med. 2002;195:1599–611.",
      "volume": "195",
      "year": "2002"
    },
    {
      "DOI": "10.1182/blood-2004-10-4093",
      "author": "W Tong",
      "doi-asserted-by": "publisher",
      "first-page": "4604",
      "journal-title": "Blood",
      "key": "414_CR43",
      "unstructured": "Tong W, Zhang J, Lodish HF. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood. 2005;105:4604–12.",
      "volume": "105",
      "year": "2005"
    },
    {
      "DOI": "10.1002/pbc.25271",
      "author": "N Hyakuna",
      "doi-asserted-by": "publisher",
      "first-page": "542",
      "journal-title": "Pediatr Blood Cancer",
      "key": "414_CR44",
      "unstructured": "Hyakuna N, Muramatsu H, Higa T, Chinen Y, Wang X, Kojima S. Germline mutation of CBL is associated with moyamoya disease in a child with juvenile myelomonocytic leukemia and Noonan syndrome-like disorder. Pediatr Blood Cancer. 2015;62:542–4.",
      "volume": "62",
      "year": "2015"
    },
    {
      "DOI": "10.3389/fped.2017.00113",
      "author": "EG Seaby",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Front Pediatr",
      "key": "414_CR45",
      "unstructured": "Seaby EG, Gilbert RD, Andreoletti G, Pengelly RJ, Mercer C, Hunt D, et al. Unexpected findings in a child with atypical hemolytic uremic syndrome: an example of how genomics is changing the clinical diagnostic paradigm. Front Pediatr. 2017;5:1–6.",
      "volume": "5",
      "year": "2017"
    },
    {
      "DOI": "10.1212/NXG.0000000000000448",
      "author": "Y Hong",
      "doi-asserted-by": "publisher",
      "first-page": "e448",
      "issue": "4",
      "journal-title": "Neurology Genetics",
      "key": "414_CR46",
      "unstructured": "Hong Y, Keylock A, Jensen B, Jacques TS, Ogunbiyi O, Omoyinmi E, et al. Cerebral arteriopathy associated with heterozygous variants in the casitas B-lineage lymphoma gene. Neurology Genetics. 2020;6(4):e448. https://doi.org/10.1212/NXG.0000000000000448.",
      "volume": "6",
      "year": "2020"
    },
    {
      "DOI": "10.1046/j.1538-7836.2003.00464.x",
      "author": "JM Auger",
      "doi-asserted-by": "publisher",
      "first-page": "2419",
      "journal-title": "J Thromb Haemost J Thromb Haemost",
      "key": "414_CR47",
      "unstructured": "Auger JM, Best D, Snell DC, Wilde JI, Watson SP. c-Cbl negatively regulates platelet activation by glycoprotein VI. J Thromb Haemost J Thromb Haemost. 2003;1:2419–26.",
      "volume": "1",
      "year": "2003"
    },
    {
      "key": "414_CR48",
      "unstructured": "Devalliè J, Atrice Charreau B. The adaptor Lnk (SH2B3): An emerging regulator in vascular cells and a link between immune and inflammatory signaling."
    },
    {
      "DOI": "10.1042/BJ20050892",
      "author": "CBF Thien",
      "doi-asserted-by": "publisher",
      "first-page": "153",
      "journal-title": "Biochem J",
      "key": "414_CR49",
      "unstructured": "Thien CBF, Langdon WY. c-Cbl and Cbl-b ubiquitin ligases: Substrate diversity and the negative regulation of signalling responses. Biochem J. 2005;391:153–66.",
      "volume": "391",
      "year": "2005"
    },
    {
      "author": "M Sanada",
      "first-page": "904",
      "journal-title": "Nat Publish Group",
      "key": "414_CR50",
      "unstructured": "Sanada M, Suzuki T, Shih LY, Otsu M, Kato M, Yamazaki S, et al. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. Nat Publish Group. 2009;460:904–8.",
      "volume": "460",
      "year": "2009"
    },
    {
      "DOI": "10.1038/35003235",
      "author": "YJ Chiang",
      "doi-asserted-by": "publisher",
      "first-page": "216",
      "journal-title": "Nature",
      "key": "414_CR51",
      "unstructured": "Chiang YJ, Kole HK, Brown K, Naramura M, Fukuhara S, Hu RJ, et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature. 2000;403:216–20.",
      "volume": "403",
      "year": "2000"
    },
    {
      "DOI": "10.1101/gad.297135.117",
      "author": "K Lv",
      "doi-asserted-by": "publisher",
      "first-page": "1007",
      "journal-title": "Genes Dev",
      "key": "414_CR52",
      "unstructured": "Lv K, Jiang J, Donaghy R, Riling CR, Cheng Y, Chandra V, et al. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies. Genes Dev. 2017;31:1007–23.",
      "volume": "31",
      "year": "2017"
    }
  ],
  "reference-count": 52,
  "references-count": 52,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-022-00414-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "16"
}